Sofia Jarnum - Publications

Imlifidase-generated Single-cleaved IgG: Implications for Transplantation.

Journal: Transplantation

Published: December 30, 2021

Administration of immunoglobulin G-degrading enzyme of Streptococcus pyogenes (IdeS) for persistent anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura in clinical remission.

Journal: British journal of haematology

Published: November 30, 2018

Streptococcus pyogenes Infection and the Human Proteome with a Special Focus on the Immunoglobulin G-cleaving Enzyme IdeS.

Journal: Molecular & cellular proteomics : MCP

Published: December 04, 2017

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: October 13, 2017

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.

Journal: The New England journal of medicine

Published: August 03, 2017

Enzymatic Inactivation of Endogenous IgG by IdeS Enhances Therapeutic Antibody Efficacy.

Journal: Molecular cancer therapeutics

Published: February 01, 2017

IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barré syndrome.

Journal: Experimental neurology

Published: December 04, 2016

The Bacterial Enzyme IdeS Cleaves the IgG-Type of B Cell Receptor (BCR), Abolishes BCR-Mediated Cell Signaling, and Inhibits Memory B Cell Activation.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: August 28, 2015

Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic Opportunity.

Journal: PloS one

Published: November 24, 2014